Literature DB >> 1718871

Expression of adhesion molecules in leprosy lesions.

L Sullivan1, S Sano, C Pirmez, P Salgame, C Mueller, F Hofman, K Uyemura, T H Rea, B R Bloom, R L Modlin.   

Abstract

Leprosy presents as a clinical spectrum that is precisely paralleled by a spectrum of immunological reactivity. The disease provides a useful and accessible model, in this case in the skin, in which to study the dynamics of cellular immune responses to an infectious pathogen, including the role of adhesion molecules in those responses. In lesions characterized by strong delayed-type hypersensitivity against Mycobacterium leprae (tuberculoid, reversal reaction, and Mitsuda reaction), the overlying epidermis exhibited pronounced keratinocyte intracellular adhesion molecule 1 (ICAM-1) expression and contained lymphocytes expressing the ICAM-1 ligand, LFA-1. Conversely, in lesions in which delayed-type hypersensitivity was lacking (lepromatous), keratinocyte ICAM-1 expression was low and LFA-1+ lymphocytes were rare. Expression of these adhesion molecules on the cells within the dermal granulomas was equivalent throughout the spectrum of leprosy. The percentage of lymphocytes in these granulomas containing mRNA coding for gamma interferon and tumor necrosis factor alpha, synergistic regulators of ICAM-1 expression, paralleled epidermal ICAM-1 expression. In lesions of erythema nodosum leprosum, a reactional state of lepromatous leprosy thought to be due to immune complex deposition, keratinocyte ICAM-1 expression and gamma interferon mRNA+ cells were both prominent. Antibodies to LFA-1 and ICAM-1 blocked the response of both alpha beta and gamma delta T-cell clones in vitro to mycobacteria. Overall, the expression of adhesion molecules by immunocompetent epidermal cells, as well as the cytokines which regulate such expression, correlates with the outcome of the host response to infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718871      PMCID: PMC259010          DOI: 10.1128/iai.59.11.4154-4160.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Immune complexes and complement hypercatabolism in patients with leprosy.

Authors:  B Bjorvatn; R S Barnetson; G Kronvall; R H Zubler; P H Lambert
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

2.  Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors.

Authors:  J N Barker; V Sarma; R S Mitra; V M Dixit; B J Nickoloff
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

3.  The pathogenesis of the early skin lesion in leprosy.

Authors:  D S Ridley
Journal:  J Pathol       Date:  1973-11       Impact factor: 7.996

4.  Mechanisms of reactions in leprosy.

Authors:  M F Waters; J L Turk; S N Wemambu
Journal:  Int J Lepr Other Mycobact Dis       Date:  1971 Apr-Jun

5.  Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.

Authors:  S N Wemambu; J L Turk; M F Waters; R J Rees
Journal:  Lancet       Date:  1969-11-01       Impact factor: 79.321

6.  Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy.

Authors:  T H Rea; N E Levan
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-06

7.  The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.

Authors:  A M Krensky; F Sanchez-Madrid; E Robbins; J A Nagy; T A Springer; S J Burakoff
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Serum and tissue lysozyme in leprosy.

Authors:  T H Rea; C R Taylor
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

Authors:  G Bjune; R S Barnetson; D S Ridley; G Kronvall
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

10.  Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones.

Authors:  J R Lamb; D D Eckels; P Lake; A H Johnson; R J Hartzman; J N Woody
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

View more
  15 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Immunocytochemical localization of inducible nitric oxide synthase and transforming growth factor-beta (TGF-beta) in leprosy lesions.

Authors:  S Khanolkar-Young; D Snowdon; D N Lockwood
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

3.  Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.

Authors:  J N Agrewala; B Kumar; H Vohra
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Roles of tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta), and IL-10 in the modulation of intercellular adhesion molecule-1 (ICAM-1) expression by macrophages during mycobacterial infection.

Authors:  H Tomioka; T Shimizu; W W Maw; K Ogasawara
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

5.  Cytokine secretion and adhesion molecule expression by granuloma T lymphocytes in Mycobacterium avium infection.

Authors:  R E Sacco; R J Jensen; C O Thoen; M Sandor; J Weinstock; R G Lynch; M O Dailey
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Nerve and skin damage in leprosy is associated with increased intralesional heat shock protein.

Authors:  S Khanolkar-Young; D B Young; M J Colston; J N Stanley; D N Lockwood
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Tumor necrosis factor production in patients with leprosy.

Authors:  P F Barnes; D Chatterjee; P J Brennan; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 8.  Thalidomide: rationale for renewed use in immunological disorders.

Authors:  U Schuler; G Ehninger
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

9.  Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions.

Authors:  S Khanolkar-Young; N Rayment; P M Brickell; D R Katz; S Vinayakumar; M J Colston; D N Lockwood
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

10.  Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells.

Authors:  G M López Ramírez; W N Rom; C Ciotoli; A Talbot; F Martiniuk; B Cronstein; J Reibman
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.